chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lips got really swollen; Cold symptoms; hives were really bad and covered my whole body/chest/neck/whole torso/right arm/left leg; soreness in arm for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm for 24 hours), LIP SWELLING (lips got really swollen), NASOPHARYNGITIS (Cold symptoms) and URTICARIA (hives were really bad and covered my whole body/chest/neck/whole torso/right arm/left leg) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder (Lupus).    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm for 24 hours). On 05-Mar-2021, the patient experienced LIP SWELLING (lips got really swollen), NASOPHARYNGITIS (Cold symptoms) and URTICARIA (hives were really bad and covered my whole body/chest/neck/whole torso/right arm/left leg). The patient was treated with AMMONIUM CHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ORIGINAL) for Hives, at an unspecified dose and frequency. On 05-Mar-2021, PAIN IN EXTREMITY (soreness in arm for 24 hours) had resolved. At the time of the report, LIP SWELLING (lips got really swollen), NASOPHARYNGITIS (Cold symptoms) and URTICARIA (hives were really bad and covered my whole body/chest/neck/whole torso/right arm/left leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported.
Redness in the shot given area (small red area -somewhat hard to the touch) acey body, low grade fever, chills and diarrhea.
First reaction - swelled up everywhere. Second reaction - happened at car wash. Eyes rolled up and hit the ground; had seizure. Back of head required stitches. Loss of blood. Had 2 more seizures. No previous history of seizure in patient. Annual follow up on 03/03: "Pt did not recover from adverse events. Just 3 months ago another seizure occurred at home.  An ambulance came to the scene. After the first 3 seizures she was placed on Dilantin for 6 months.  11 months after the first episode, 5 months after being off Dilantin the fourth seizure occurred. Pt tries to do well in her courses at the university but finds it hard to find transportation and lives in fear of when another will occur. She is 27 years old and until the seizure reported from the MMR shot-she had never before experienced anything like the adverse reaction before. Thank you!"
This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Nov-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue). On 01-Nov-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Oct-2021: Follow-up received on 15 Oct 2021 contain patient identifier details.
Severe chills and sweating but feeling cold. Fever of 104.5. Massive headache.
My 2nd dose was scheduled on Monday Apr 19, 2021 at 12:30 PM. I didn't have any side effects for the first few hours, I started itching and had a terrible swell by the evening and took a Tylenol. I had my PCP appointment on Wednesday Apr 21, 2021, my vaccination injection side was swollen terribly at this point and the Nurse asked me about it. I gave blood for various tests and came home. An hour later my left upper back side was paining and spasming and for pretty bad by the end of the day. The next day the spasms spread to my chest and it was becoming unbearable, I was confined to the couch and worked that day, with an intention to go the Emergency if things got even worse. Come Friday, the pain for concentrated to the center of the chest and was more or less the same severity as the day before. My symptoms subsided on Saturday by 80% and were gone on Sunday.   I tried to make a Cardiologist appointment the following monday Apr 28 (to be seen that week), but didn't get an Appt. Therefore I got a referral from my PCP to be seen at Cardiology. The Cardiologist said that she saw a blip in my EKG and wondered if I had a mild heart attack during those 3 days Apr 23-Apr26. She recommended I get a Stress Test done which is scheduled in early July. My PCP and I spoke about this event during my next video chat appt and when she asked my why I didn't go to urgent care, I told her that I probably had an adverse reaction to the vaccine, which is why I didn't do, but this was just a suspicion (I get SVT episodes and my pain tolerance is high).   The recent news from 4 days ago about Myocarditis and Pericarditis being a side effect in rare cases has prompted me to report this now. Hope this is helpful and I appreciate anything you may be able to share with me.
Information has been received from a certified nurse midwife concerning an 18 year old female who on 20-NOV-2006 was vaccinated with her first dose of GARDASIL vaccine (yeast) (Lot#653937/0637F). Concomitant therapy included (PREVACID), acetaminophen (+) (ULTRACET), (MSD), (ZOLOFT), (CLARINEX) and (YASMIN). On 20-NOV-2006, a few minutes later after the vaccination, the patient fainted in the office. The patient was fully recovered from fainting a few minutes later. The patient later completed the series without any other symptoms. The patient seek medical attention. Additional information has been requested.
Severe pain when vaccination administered to left arm.  Pain has persisted for 1.5 years - not improving or worsening.  Pain is constantly low grade and severe with certain movements of arm.
Systemic: Dizziness / Lightheadness-Mild, Additional Details: Patient felt dizziness after vaccination,after 5 minutes she felt a little better, and then after 30 minutes she felt fine.
Approximately 10 minutes after receiving COVID-19 vaccine experienced "leg heaviness" --given 25mg PO benadryl and observed. 10 minutes later developed nausea and multiple episodes of gagging and emesis. Then reported "throat tightness" and difficulty breathing-- given 0.3mg IM Epi and EMS called. Taken to hospital via ambulance.
glaucoma; This is a spontaneous report from a contactable consumer (patient's wife) received via a Pfizer-sponsored program. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 14Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that second dose was scheduled on 04Feb2021. It was reported that the patient has an appointment for glaucoma injection on 29Jan2021 in his eye. Reporter asked if okay to get it or reschedule his appointment. Outcome of the event was unknown.   Information on the batch/lot number has been requested.
At 10 am on 4/23/21, the patient received his second Pfizer dose and became unresponsive and started to seize.  He was sitting in the waiting area to be monitored when this occurred.  The nurse and I went to assist him and I told staff to call 911. The patient quickly became responsive and said that he was fine and I told staff to cancel the call for an ambulance.  I could tell he was shaken up and I asked him about any pertinent medical and medication history.  He says he has high blood pressure but took his medication that day.  He did not eat or drink anything and we gave him water and a granola bar to eat while he was waiting for his family member to pick him up.  I recommended he call his provider to inform him or her what had happened and to report the side effect to VSAFE.  I checked his blood pressure and it was 159/90 which was considered normal for him.  His brother arrived and was thankful for the help.
Report 200031919-1 describes rash in a 50 year old female who received the Hepatitis b vaccine.  Reportedly, the vaccinee has no medical history, allergies, concomitant medications, or illness at the time of vaccination. On 26-Sep-00, 15;45, the vaccinee received her third IM-left deltoid dose of the Hepatitis-b vaccine.   Approximately thirty minutes later, she developed a fine rash around the injection site extending to the upper trunk.  As of 25-Oct-00, the outcome of the event is resolved.
Noted developing "rash" on 11/21/2010.  Rash progressed and visited MD 11/22.  No specific treatment advised at that time.  Rash continued to evolve and at f/u MD visit 11/24 diagnosed as shingles and prescribed topical acyclovir.  Progression halted and lesions resolving.
15 month old patient received a dose of received Quadracel vaccine in error with no adverse event; 15 month old patient received a dose of received Quadracel vaccine (intended Daptacel) in error with no adverse event; Initial information regarding an unsolicited valid non-serious case was received from an other health professional via medical information (Reference number- 00502121).   This case involves a 15 month old male patient who received a 0.5 mL dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] [lot number: C5772AA, expiry date: 17-Sep-2022] via intramuscular route at an left thigh for prophylactic vaccination on 02-Mar-201 in error as patient was intended to receive DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL]) [lot number, expiry date and other dosing details not applicable] (product administered to patient of inappropriate age and wrong product administered). (latency: at the same time of vaccination)  Medical history, medical treatment, vaccination and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) and HIB VACCINE CONJ (HIB VACCINE CONJ) (HIB-PRPT).  It was a case of actual medication error due to inappropriate age at vaccine administration and wrong product administered.   It was reported that, there have been several patients 15 months of age had been given QUADRACEL and would like to know how safe that was since it was not meant for that age group. Nurse reports that they typically use Pentacel for children's 15-month vaccines.  This 9-month-old child was receiving his 15-month.  The office was out of Pentacel, so the medical assistant (MA) administered HIB-PRPT with QUADRACEL (intended DAPTACEL) and PREVNAR 13.  No adverse effects reported at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
This spontaneous report was received from a healthcare working referring to a 10 week old patient of unknown gender. The patient's concurrent conditions and medical histories were not provided. On 29-OCT-2015, the patient was vaccinated with a dose of improperly stored ROTATEQ, orally (dose was unknown, lot # K023532, expiration date 21-JUN-2016). Concomitant medication was not reported. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Information has been received from a physician concerning a female patient in her "mid 40's" with no allergies or pertinent medical history who on 07-JUL-2008 was vaccinated SC with a 0.5 mL first dose of MMR II (lot# not reported). There was no concomitant medication. On 19-JUL-2008, the patient experienced a fever of 103 degrees F, nausea and dizziness. The patient was examined in the office. A complete blood count was normal and the results of a chest xray, ordered on 28-JUL-2008, were pending. The patient's fever, nausea, and dizziness persisted. No further information is available. No product quality complaint was involved. Follow up information was received from the doctor who reported the patient was vaccinated with MMR II and yellow fever vaccine  on 07-JUL-2008. The patient was seen on 25-JUL-2008 and 28-JUL-2008. The patient experienced a fever (T 102), diaphoresis and fatigue, then heart racing, some shortness of breath, and cough. It was reported that the patient's vial signs were stable and the patient was afebrile. On 28-JUL-2008 the patient's chest x-ray was within normal limits. The outcome was not reported. Additional information is not expected.
Pt.'s Daughter states that after receiving the 3rd Booster of Phizer 10/15/2021 (received High-Dose Influenza) , started experiencing symptoms 10/16/2021 of confusion/headache before going into A-Fib and a Blood Clot in the Brain resulting in Mild Stroke. Hospitalized 10/16/2021/ discharged 10/19/2021. Cardiologist appt. 10/21/2021, Neurologist 11/09/2021 for Follow-Up.
This spontaneous report as received from a pharmacy student refers to a patient of unknown age (gender not reported). On 11-DEC-2012, the patient was vaccinated with a dose of live, oral, ROTATEQ that was exposed to 17 C for 60 hours, lot number reported as "H010322", exp. date 30-NOV-2013 (dose, route were not reported). No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. The patient's outcome was unknown. Additional information has been requested.
Nearly passed out, cold sweats and immediate fever chills (intermittently).  Ringing in ears, pressure behind eyes (lasted 30 seconds).   Laid down on floor with feet up on chair, drank water, recovered in 10 minutes.
side effects hit hard; This case was reported by a consumer via call center representative and described the occurrence of adverse event in a 56-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had shingles 3 years ago).   On 13th May 2019, the patient received the 1st dose of Shingrix. In May 2019, less than a week after receiving Shingrix, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown.   It was unknown if the reporter considered the adverse event to be related to Shingrix.  Additional details were provided as follows: The patient stated that side effects really hit hard. The patient would plan better for 2nd shot of Shingrix. The reporter advised to the patient to refer Healthcare provider as a primary resource for patient care. The reporter asked to the patient with respect to what experienced after receiving the first Shingrix shot.
This spontaneous report as received from a licensed practical nurse refers to an unspecified number of patients of unknown age and gender. The nurse reported that, on an unknown date, an unspecified amount of doses of VARIVAX (Merck) 0.5 ml, subcutaneous (lot # and expiration date were not reported) that underwent a temperature excursion was administered to an unspecified amount of patients. No adverse effect was reported. Follow up information has been received from a licensed practical nurse on 23-JAN-2015. It was reported that there was no lot numbers, expiration dates and patient data readily available. Nurse reported that no adverse event had been reported following administration of vaccinations. Follow up information has been received from a licensed practical nurse on 23-JAN-2015. The nurse stated that 9 doses of VARIVAX (Merck) with lot number K006137 were administered since fridge incident (since 09-DEC-2014). Follow up information has been received from a licensed practical nurse on 18-MAR-2015. On 11-AUG-2013, the patient of unknown age and gender was vaccinated with a dose of VARIVAX (Merck) that underwent a temperature excursion. This is one of several reports received from the same reporter. Additional information is not expected, all available information has been received.
having trouble breathing; low grade fever; headache; Chills; sweat; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweat), DYSPNOEA (having trouble breathing), CHILLS (Chills), PYREXIA (low grade fever) and HEADACHE (headache) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN and FLUOXETINE HYDROCHLORIDE (PROZAC) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced HYPERHIDROSIS (sweat) and CHILLS (Chills). On 07-Mar-2021, the patient experienced HEADACHE (headache). On an unknown date, the patient experienced DYSPNOEA (having trouble breathing) and PYREXIA (low grade fever). At the time of the report, HYPERHIDROSIS (sweat), DYSPNOEA (having trouble breathing), CHILLS (Chills), PYREXIA (low grade fever) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
dizzy; BP dropped to 117/79.; This is a spontaneous report from a   consumer.  A 75-years-old male patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number:  EL9265, via an unspecified route of administration in left arm,from 03Feb2021 as a single doseE for COVID-19 immunization .  Medical history included  a stroke and high blood pressure .  Concomitant medication included oral clopidogrel (CLOPIDOGREL), 75 mg once a day for a storkeand  apixaban (ELIQUIS) 5 mg 2x/day oral for blood clots.  On 03Feb2021Patient had a reaction with the first dose of the Pfizer vaccine. He got a little dizzy and his BP dropped to 117/79. He wants to know if it is safe to take the second dose.. Patient states that he had a mild reaction to the COVID shot on 03Feb2021. Patient states that he got kind of dizzy, and his blood pressure dropped to 117. Patient states that his reaction lasted about an hour, and he had no other problems. Patient is wondering if he should get the second dose, or if he should not take some of his blood thinning medications on the same day as his second dose. Patient got his first dose of the product on 03Feb2021, and the side effects occurred that same day, just after the patient left the clinic, about 15 minutes later. Patient reports that he got kind of dizzy and he checked his blood pressure which was 117/79. Patient states that the dizziness lasted about an hour, and he did not check his blood pressure again after that. The outcome of the events was not reported.
It was muscle spasms and I have this little thing in my kidney and it hurt real bad and it was something new I never felt before. So I went to the clinic. They did a few things. The nurse I saw the next day explained it was more musculoskeletal issue. I felt better by the next day and it went away.
Patient became light headed, dizzy, pale and complained of trouble breathing, 911 was called and EMT's arrived. Symptoms resolved and patient did not require hospitalization.
fever of 101 plus for 12 hours, headache for 5 days, Fever of 99.-99.8 for five days
Patient received vaccine on 10/28/08 and called this morning reporting redness and swelling by injection site and a rash. Flat rash not raised on arms, torso, legs.
Headache, Myalgia, Fever, fatigue, cold sweats, soreness at injection site Narrative:
Initial unsolicited misuse report received from a physician on 21 August 2015. A 34-year-old female patient, whose concomitant medications were not reported, had received an intramuscular dose of TYPHIM VI (batch number K1536, expiry date 16 Sept 2016) in left deltoid and a subcutaneous dose of MENACTRA (batch number U5021AA, expiry date 14 July 2016) on 19 August 2015. Reporter denied to provide information regarding illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects and medical conditions. It was a case of inappropriate route of vaccination, as the patient received dose of MENACTRA via subcutaneous route instead of intramuscular route. On 21 August 2015, two days after vaccination, the patient developed an oval area of redness measuring 2.5 cm. The patient required emergency room or physician visit. Laboratory investigations were not reported. It was reported that the physician did not prescribe medical treatment to patient. At the time of this report, the outcome of event was unknown. Documents held by sender: none.
Patient/Employee stated about 15-20 minutes after vaccination, he got a metallic taste in his mouth and his legs started having numbness with tingling and this lasted until 8:00 pm that night.
I began to have a rash and then severe swelling of my lymph modes to the size of golf balls and a fever of 102 that was hard to reduce, I also had vomiting and muscle/body aches.
Systemic: Abdominal Pain-Mild, Systemic: Pancreatitis-Mild, Additional Details: Pt stated she got diagnosed with pancreasetits a few months after recieving covid vaccine. told her not a reported side effects but would submit a VAERS in case patterns are discovered. Told patient to let md know when she had her covid shot as well.
Information has been received from a registered nurse concerning a 14 year old female who on 17-MAY-2007 was vaccinated with GARDASIL. On 17-MAY-2007 the patient experienced arm pain, dizziness and rash from the injection site to her elbow. On an unspecified date the patient recovered from her experiences. On 19-JUL-2007 the patient received her second dose of GARDASIL. On 19-JUL-2007 the patient experienced arm pain, dizziness and rash from the injection site to her elbow. On an unspecified date, the patient recovered from her experiences. The patient did visit the physician's office regarding this experience. Additional information has been requested.
Headache, weakness, exhaustion, couldn't stay awake more than an hour or two, like a bad flu. I was too weak to walk past the living room and bathroom, or I would have gone to the doctor. It lasted 5 full days. I woke up feeling better day 6 and was able to stay awake and was able to walk around the house by day 7.
I had dizziness; I haven't experienced dizziness before. I had increased headaches. The medication helped with the dizziness but not with the  headaches. The med. makes me tired. I am still experiencing intermittent dizzy spells and headaches -the headaches are just usually one one side but it varies. The migraines that I got before the vaccines seems to have increased since the vaccines.
fever for 3 days following DTP, w/unusual cry & some vacant staring; sx better each time was given APAP, but returned when APAP wore off; family did not seek medical care or report this until today;